The 2026 edition of the ESMO Breast Cancer Congress has concluded, leaving behind a profound roadmap for...
Clinical Oncology Education
A landmark study published in JAMA Network Open has ignited a significant conversation within the oncology community,...
Main Facts: Redefining an Indolent Malignancy Primary cutaneous anaplastic large cell lymphoma (pcALCL) represents a unique challenge...
Glioblastoma (GBM), the most lethal primary brain malignancy, has long frustrated oncologists and researchers. Characterized by aggressive...
The history of melflufen (melphalan flufenamide) in the treatment of relapsed or refractory multiple myeloma (RRMM) serves...
Introduction The 48th San Antonio Breast Cancer Symposium (SABCS), held from December 9–12, 2025, at the Henry...
In the meticulous world of oncological research, where the difference between a successful breakthrough and a failed...
By Medical Science Editorial Staff Published: May 10, 2026 | Source: Cancers (MDPI) The promise of artificial...
Metastatic breast cancer (MBC) remains the most formidable adversary in modern oncology, responsible for approximately 90% of...
As climate change accelerates, the frequency and intensity of wildfires have transformed from seasonal regional concerns into...
